Drawing for CADOR

USPTO serial 79054583

CADOR

Reviewed by CopyMark Law Group

Reg. 3616297Status 709
Filing date
Status date
Registration date
May 5, 2009
Examiner
WILKE, JOHN
Law office
GENERIC WEB UPDATE

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with CADOR?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
001Chemical, biochemical and biotechnological products for industrial and scientific purposes and laboratory analysis, namely, buffers, solvents, and natural or synthetic biopolymers, namely, nucleic acids, oligonucleotides, proteins, and macromolecules; chemical reagents and solvents for non medical purposes, namely, for sample preparation, modification and manipulation of cells as well as for labeling, separation, isolation, purification, amplification and/or analysis of natural or synthetic biopolymers, namely, nucleic acids, oligonucleotides, proteins, macromolecules and biologically active substances; kits for research purposes comprising chemical products, namely, reagents and solvents for sample preparation, modification and manipulation of samples and cells as well as for labeling, separating, isolating, purifying, amplifying and/or analyzing natural or synthetic biopolymers, namely, nucleic acids, oligonucleotides, proteins, macromolecules and biologically active substances, namely, nucleic acids and oligonucleotides from biological or biochemical sample materialSECTION 71 - CANCELLED—
005[ Pharmaceutical and veterinary medical products, namely, buffers, solvents, oligonucleotides, proteins, macromolecules and biologically active substances; products for healthcare purposes, namely, buffers, solvents, oligonucleotides, proteins, macromolecules and biologically active substances; ] diagnostic preparations for medical or veterinary use; products for medical or veterinary medical purposes, namely, diagnostic preparations used for sample preparation, modification and manipulation of cells as well as for labeling, separation, isolation, purification, amplification and/or analysis of natural or synthetic biopolymers, namely, nucleic acids, oligonucleotides, proteins, macromolecules and biologically active substances; chemical, biochemical and biotechnological products for medical or veterinary purposes, namely, reagents and solvents for sample preparation, modification and manipulation of cells as well as for labeling, separating, isolating, purifying, amplifying and/or analyzing natural or synthetic biopolymers, namely, nucleic acids, oligonucleotides, proteins, macromolecules and biologically active substances for diagnostic purposes; in vitro diagnostic preparations for medical purposes; kits comprising products, namely, reagents and solvents for medical and/or veterinary medical diagnostic purposes, namely, for sample preparation, modification and manipulation of cells as well as for labeling, separating, isolating, purifying, amplifying and/or analyzing natural or synthetic biopolymers, namely, nucleic acids, oligonucleotides, proteins, macromolecules and biologically active substances, namely, nucleic acids and oligonucleotides from biological or biochemical sample material; all purpose disinfectantsSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jan 14, 2022INNTTOTAL INVALIDATION PROCESSED BY THE IB—
Dec 16, 2021INTSTOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Dec 16, 2021INPCINVALIDATION PROCESSED—
Oct 26, 2021INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Feb 26, 2021C71TCANCELLED SECTION 71—
Oct 5, 2018CHLDCHANGE OF OWNER RECEIVED FROM IB—
May 5, 2018REM4COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED—
Apr 5, 2018RNWLINTERNATIONAL REGISTRATION RENEWED—
Apr 28, 2015NA75NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED—
Apr 28, 2015C75AREGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.—
Apr 28, 2015APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Apr 15, 2015ES75TEAS SECTION 71 & 15 RECEIVED—
Jan 13, 2013FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Aug 21, 2009FICSFINAL DISPOSITION NOTICE SENT TO IB—
Aug 21, 2009FIMPFINAL DISPOSITION PROCESSED—
Aug 6, 2009FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
May 5, 2009R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Feb 17, 2009PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 28, 2009NPUBNOTICE OF PUBLICATION—
Jan 12, 2009PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Jan 9, 2009CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 9, 2009XAECEXAMINER'S AMENDMENT ENTERED—
Jan 9, 2009GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jan 9, 2009GNEAEXAMINERS AMENDMENT E-MAILED—
Jan 9, 2009CNEAEXAMINERS AMENDMENT -WRITTEN—
Jan 8, 2009ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
Jan 5, 2009PBCRWITHDRAWN FROM PUB - OG REVIEW QUERY—
Dec 24, 2008PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Dec 23, 2008CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 23, 2008TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Dec 23, 2008CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 23, 2008ALIEASSIGNED TO LIE—
Dec 9, 2008TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 8, 2008TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Dec 8, 2008ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 8, 2008REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Aug 8, 2008ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 8, 2008REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Aug 1, 2008RFNTREFUSAL PROCESSED BY IB—
Jul 15, 2008RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jul 15, 2008RFRRREFUSAL PROCESSED BY MPU—
Jul 15, 2008RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jul 14, 2008CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 11, 2008DOCKASSIGNED TO EXAMINER—
Jul 11, 2008NWAPNEW APPLICATION ENTERED—
Jul 10, 2008REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance